document.write('<style type="text/css">.piribo-report-feeder h2{color: #fff;font-size: 13px;margin: 0;padding: 2px 6px 2px 6px;background: #5a7684;}.piribo-report-feeder p{margin: 0;padding: 5px 0 6px 6px;background: url(http://www.piribo.com/images/bg_report_feeder.gif) repeat-x bottom;}.piribo-report-feeder p a{color: #ea7c00;font-size: 12px;font-weight: bold;}.piribo-report-feeder .provided-by{text-align: right;margin-top: -2px;padding: 5px 10px 5px 10px;border-top: 1px solid #ea7c00;border-bottom: 2px solid #ea7c00;}.piribo-report-feeder .provided-by img{border:0;}</style>');
document.write('<div class="piribo-report-feeder"><h2>Drug  Discovery Market Research Reports </h2><p><a href="http://www.piribo.com/publications/diseases_conditions/diabetes/glucose_monitoring_devices_market_worldwide.html?aff=">Glucose Monitoring Devices Market Worldwide</a><br/>2010 – 2014</p><p><a href="http://www.piribo.com/publications/therapeutic/commercial_insight_osteoporosis.html?aff=">Commercial Insight: Osteoporosis</a><br/>Market players maximize revenue growth before the next challenging phase</p><p><a href="http://www.piribo.com/publications/biotechnology/human_embryonic_stem_cells.html?aff=">Human Embryonic Stem Cells</a><br/>A Global Market Overview</p><p><a href="http://www.piribo.com/publications/diagnostic/u_s_inherited_disease_molecular_diagnostics_markets.html?aff=">U.S. Inherited Disease Molecular Diagnostics Markets</a><br/></p><p><a href="http://www.piribo.com/publications/diseases_conditions/alzheimerrs_disease_immunotherapy_pipeline.html?aff=">Alzheimer’s Disease Immunotherapy Pipeline</a><br/>Vaccines, Therapeutic Antibodies and Emerging Strategies</p><p><a href="http://www.piribo.com/publications/treatments/commercial_insight_insomnia_strong_brand_identity_critical_differentiation_increasingly_crowded_market.html?aff=">Commercial and Pipeline Insight: Insomnia</a><br/>Future of innovative orexin drug class in doubt</p><p><a href="http://www.piribo.compipeline_insight_migraine.html?aff=">Pipeline Insight: Migraine</a><br/>Challenges ahead for first-in-class developments</p><p><a href="http://www.piribo.comstakeholder_opinions_parkinsons_disease.html?aff=">Stakeholder Opinions: Ovarian Cancer</a><br/>Approaching the era of molecular targeted therapy</p><p><a href="http://www.piribo.com/publications/diseases_conditions/cns/stakeholder_insight_multiple_sclerosis.html?aff=">Stakeholder Insight: Multiple Sclerosis</a><br/>Next generation therapies signal the start of a new era</p><p><a href="http://www.piribo.com/publications/therapeutic/multiple_sclerosis_market_forecast.html?aff=">Multiple Sclerosis Market Forecast</a><br/></p><div class="provided-by"><a href="http://www.piribo.com" onclick="return !window.open(this.href);"><img src="http://www.piribo.com/images/logo_provided_by_piribo3.gif" alt="Logo: Provided by Piribo"/></a></div></div>');